Novo, the maker of the obesity drug Wegovy, has repeatedly warned about the risks of compounded and knock-off versions of GLP ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

As millions of Americans set ambitious weight loss goals for the new year, CoreAge Rx's expansion addresses surging demand for accessible, affordable GLP-1 medications. Many patients face barriers ...

Whether it’s due to an ingredient allergy or other reasons, compounding pharmacies can help tailor a custom-made medication to meet your needs. And when drug shortages happen, they can play an ...

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more ...

Speaking at the J.P. Morgan Healthcare Conference, Doustdar said compounders recognized consumer behavior earlier than major ...

CEO Mike Doustdar shared the figure Monday at the J.P. Morgan Healthcare Conference, saying compounded versions have gained ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...